Form 4: Transcat Director Reports Sale of Common Stock and Updated Holdings

Transcat Inc. Director Christopher P. Gillette reported the sale of 456 shares of common stock and updated his beneficial ownership of derivative securities.

Summary

• Transcat Inc. Director Christopher P. Gillette reported the sale of 456 shares of the company's common stock.
• The transaction occurred on October 8, 2024, with the shares sold at a price of $119.95 per share.
• Following this reported transaction, Mr. Gillette's direct beneficial ownership of common stock is 0 shares.
• Mr. Gillette continues to hold 704 Restricted Stock Units (RSUs) which are scheduled to vest on September 11, 2025.
• He also holds 10,000 stock options with an exercise price of $109.55, which vest pro rata over five years from the grant date and expire on September 6, 2033.

Sentiment

Score: 5

Explanation: The document reports a routine insider transaction (sale of a relatively small number of shares) which is generally neutral in sentiment. It does not indicate any significant positive or negative operational or financial news for the company.

Negatives

• A director sold 456 shares of common stock, reducing direct ownership to zero.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This document is a standard SEC Form 4 filing, reporting an insider transaction. It does not provide information on broader industry trends or competitive landscape.

Stakeholder Impact

• Shareholders: The sale of 456 shares by a director is a minor transaction and is unlikely to have a significant impact on the company's stock price or investor sentiment.

Key Dates

Keywords

Transcat, TRNS, Form 4, Insider Trading, Stock Sale, Director, Beneficial Ownership, Restricted Stock Units, Stock Options